EyeWorld India September 2019 Issue

FEATURE 18 EWAP SEPTEMBER 2019 approved by the U.S. FDA earlier this year. Latanoprostene bunod (VYZULTA, Bausch + Lomb) was introduced in 2018, Dr. Cantor added. It’s a prostaglandin analog that releases nitric oxide and that may convey vasoactive effects, he said. For in-office IOP measurements, a new device on the horizon called the Correcting Applanation Tonometer Surface (CATS) prism (CATS Tonometer) has a newly designed and engineered tonometer prism tip for Goldmann applanation tonometry, Dr. Radcliffe said. The new tip will help the tonometer limit bias from corneal thickness, curvature, hysteresis, and the tear film. “It’s going to be easy for all of us to adopt the CATS prism and patients will benefit quickly,” he said. Diagnostic technology One advance within glaucoma diagnostic technology is the ability to better integrate OCT structural data with functional data to help with clinical decision-making, Dr. Cantor said. The use of OCT angiography could help specialists make an earlier glaucoma diagnosis, Dr. Trubnik said. Dr. Radcliffe said that corneal hysteresis may play a greater role in glaucoma diagnostic management going forward, specifically to indicate which eyes would do well with therapy such as MIGS and which eyes may require additional therapies. EWAP Editors’ note: Dr. Angelilli is clinical assistant professor of ophthalmology, Donald and Barbara Zucker School of Medicine, Hofstra University/Northwell, Hempstead, New York, and has no relevant financial interests. Dr. Cantor is Jay C. and Lucile L. Kahn Chair of Glaucoma Research and Education, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, and has financial interests in Carl Zeiss Meditec, Santen, Allergan, and Mati Therapeutics. Dr. Radcliffe practices at the New York Eye and Ear Infirmary, New York, and has financial interests in Aerie Pharmaceuticals and Glaukos. Dr. Trubnik practices at Ophthalmic Consultants of Long Island and has no relevant financial interests. Untitled-4 1 9/9/19 5:52 PM